The neuroprotective role of TTR is well established, with evidence of beneficial physiologic activity in AD, Lewy body disorders (such as Parkinson’s disease), and TDP-43–associated neuropathologies [44,45,47,96]. This evidence concerns the gene TTR and Parkinson disease.